Davidson Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-49
Closed -$4.62K 83
2023
Q2
$4.62K Hold
49
﹤0.01% 70
2023
Q1
$4.05K Buy
49
+11
+29% +$865 ﹤0.01% 70
2022
Q4
$2.83K Buy
38
+3
+9% +$231 ﹤0.01% 89
2022
Q3
$3K Buy
35
+7
+25% +$674 ﹤0.01% 57
2022
Q2
$3K Hold
28
﹤0.01% 47
2022
Q1
$3K Sell
28
-12,010
-100% -$1.35M ﹤0.01% 66
2021
Q4
$1.56M Buy
12,038
+487
+4% +$56.8K 0.85% 23
2021
Q3
$1.31M Sell
11,551
-1,367
-11% -$156K 0.66% 25
2021
Q2
$1.34M Sell
12,918
-415
-3% -$39.1K 0.65% 25
2021
Q1
$1.11M Sell
13,333
-16,102
-55% -$1.36M 0.58% 53
2020
Q4
$2.69M Buy
29,435
+847
+3% +$70.3K 1.51% 8
2020
Q3
$2.28M Buy
28,588
+563
+2% +$43.9K 1.45% 10
2020
Q2
$1.94M Buy
28,025
+2,018
+8% +$143K 1.71% 13
2020
Q1
$1.64M Buy
26,007
+17,322
+199% +$1.25M 2.33% 7
2019
Q4
$675K Buy
+8,685
New +$678K 0.53% 32

Other funds holding EW

Davidson Capital Management's EW Position: Q3 2023 in Review

Davidson Capital Management sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 49 shares — an estimated $4.62K sold.

Davidson Capital Management first reported a position in EW in Q4 2019 and held it in 15 quarters. The position peaked at $2.69M in Q4 2020. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Davidson Capital Management reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • Davidson Capital Management sold 49 Edwards Lifesciences shares in Q3 2023, an estimated $4.62K.
  • Davidson Capital Management first reported a position in Edwards Lifesciences in Q4 2019 and held it in 15 quarters.
  • Davidson Capital Management's Edwards Lifesciences position peaked at $2.69M in Q4 2020.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Davidson Capital Management's 13F filing for Q3 2023, filed 31 Oct 2023.